Eric Adler

A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation

Hypertrophic cardiomyopathy

Phenocopies of Hypertrophic Cardiomyopathy

Alcoholic cardiomyopathy: an update

Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Precision Genetic Therapies: Balancing Risk and Benefit in Patients with Heart Failure

Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired

Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure

International Consensus on Differential Diagnosis and Management of Patients With Danon Disease

Applications of Gene Therapy in Cardiomyopathies

Gene therapy vector-related myocarditis

Gene therapy for heart failure and cardiomyopathies

Comparison of two donor‐derived cell‐free DNA tests and a blood gene‐expression profile test in heart transplantation

Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care

PROMIS: Physical, Mental and Social Health Outcomes Improve From Before to Early After LVAD Implant: Findings From the Mechanical Circulatory Support: Measures of Adjustment and Quality of Life (MCS A-QOL) Study

Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis

Acute Myocarditis Associated With Desmosomal Gene Variants

State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation

Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics

Myocarditis After BNT162b2 and mRNA-1273 Vaccination

Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients

Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity

Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias

Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy

Update on acute myocarditis

Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease

Efficacy of Tafamidis by Baseline 6-minute Walk Test Distance in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)

Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction